JUL 23, 2021 11:41 AM PDT

New Drug Eradicates Breast Cancer Tumors in Days

WRITTEN BY: Annie Lennon

A new drug can kill between 95 and 100% of cancer cells in mice with human estrogen-receptor-positive breast cancer. The study was published in Science Translational Medicine by researchers led by the University of Illinois at Urbana-Champaign. 

The newly developed drug is called ErSO and works by binding to estrogen receptors present in a vast majority of breast tumors. After binding to the receptors, it over-activates a pathway called the anticipatory Unfolded Protein Response. This releases an excess of proteins that selectively kill estrogen-receptor-containing breast cancer cells. 

In tests with mice, the researchers found that ErSO could kill 99% of human breast cancer cells, as well as their metastases in bone, brain, liver, and lungs within three days. They added that the drug has no effect on cells that lack estrogen receptors and that it doesn't affect healthy cells, even if they have estrogen receptors. 

This may explain why the drug had no detectable side effects in mice. The researchers also noted that the drug was well tolerated in rats and dogs, too, even at much higher doses than necessary for therapeutic efficacy. 

"Even when a few breast cancer cells do survive, enabling tumors to regrow over several months, the tumors that regrow remain completely sensitive to retreatment with ErSO," said David Shapiro, lead author of the research. 

"It is striking that ErSO caused the rapid destruction of most lung, bone and liver metastases and dramatic shrinkage of brain metastases, since tumors that have spread to other sites in the body are responsible for most breast cancer deaths."

As around 75% of breast cancers are estrogen-receptive positive, the new drug may one day be able to treat the most common form of breast cancer. The researchers added that as ErSO doesn't require many estrogen receptors to work, it may additionally work against breast cancers that are not estrogen-receptive positive. 

The pharmaceutical company Bayer AG will soon start the process to enter ErSO in human clinical trials for estrogen-receptor-positive breast cancers. In the meantime, the researchers will investigate whether the drug could work against other kinds of cancers that contain estrogen receptors. 

 

Sources: Science Translational MedicineScience Daily

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
JUN 09, 2021
Technology
Computer Program Generates Effective, Clinically-valid Treatment Plans for Cancer Patients
JUN 09, 2021
Computer Program Generates Effective, Clinically-valid Treatment Plans for Cancer Patients
In a recent study published in Nature Medicine, researchers at the Princess Margaret Cancer Centre offer evidence for th ...
JUN 27, 2021
Cancer
Are e-cigarettes actually helpful for smoking cessation?
JUN 27, 2021
Are e-cigarettes actually helpful for smoking cessation?
New research published in The Lancet Public Health reports on a study that looked at interventions targeting e-cigarette ...
AUG 07, 2021
Cancer
New Drug Combo Eliminates Pancreatic Cancer in Mice
AUG 07, 2021
New Drug Combo Eliminates Pancreatic Cancer in Mice
A combination of three immunotherapy drugs can eliminate pancreatic tumors in mice. The study was published in Canc ...
AUG 18, 2021
Technology
Tracking System Maps How Cancer Cells Evolve, Providing New Treatment Insights
AUG 18, 2021
Tracking System Maps How Cancer Cells Evolve, Providing New Treatment Insights
All cells in a tumor share some genetic similarities, but also have key differences, often hindering effective treatment ...
AUG 18, 2021
Cell & Molecular Biology
Insight Into an Antiviral Enzyme That Can Impact Cancer Cells
AUG 18, 2021
Insight Into an Antiviral Enzyme That Can Impact Cancer Cells
For many years, researchers have studied how an enzyme called APOBEC3 can help protect the body from pathogenic viruses, ...
SEP 18, 2021
Genetics & Genomics
Cancer Genes Might Aim for the Immune System, Not Growth Promotion
SEP 18, 2021
Cancer Genes Might Aim for the Immune System, Not Growth Promotion
The DNA in our cells can accumulate damage over may years. Environmental influences like UV light or cigarette smoke may ...
Loading Comments...